Skip to main content
PRQR logo
PRQR
(NASDAQ)
ProQR Therapeutics N.V.
$1.71-- (--)
Loading... - Market loading

ProQR Therapeutics (PRQR) Stock Price & Financial Analysis

ProQR Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.63 - $1.74
52-Week High$3.10
52-Week Low$1.07
Open$1.70
Volume241.15K
Average Volume (3M)241.15K
Market Cap180.14M
Shares Outstanding105.34M
Price to Sales (P/S)10.06
Price to Book (P/B)2.74
EV/EBITDA-1.68
Revenue (TTM)17.89M
Net Income (TTM)-49.04M
Free Cash Flow (TTM)-56.99M
EPS (TTM)$-0.47
Profit Margin-274.20%
Operating Margin-286.18%
Return on Equity (ROE)-74.59%
Debt to Equity0.26
50-Day MA$1.59
200-Day MA$2.06
52-Week Change32.56%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About ProQR Therapeutics

What is the current stock price for PRQR?

As of the latest trading session, PRQR stock trades at $1.71. The 52-week range is $1.07–$3.10, with a day range of $1.63–$1.74.

What is the P/E ratio for PRQR?

The P/E ratio (Price-to-Earnings) for PRQR is shown in the Key Statistics section. This valuation metric helps compare ProQR Therapeutics N.V. to industry peers.

Does PRQR pay dividends?

ProQR Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PRQR?

Analyst ratings and recommendations for PRQR are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of PRQR?

ProQR Therapeutics's market capitalization is $180.1M, classifying it as a micro-cap company. ProQR Therapeutics operates in the Healthcare sector within the Biotechnology industry.